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Summary
 
The 
 
nfkb
 
2 gene is a member of the Rel/NF-
 
k
 
B family of transcription factors. COOH-termi-
nal deletions and rearrangements of this gene have been associated with the development of
human cutaneous T cell lymphomas, chronic lymphocytic leukemias, and multiple myelomas.
To further investigate the function of NF-
 
k
 
B2, we have generated mutant mice carrying a germ-
line mutation of the 
 
nfkb
 
2 gene by homologous recombination. NF-
 
k
 
B2–deficient mice
showed a marked reduction in the B cell compartment in spleen, bone marrow, and lymph
nodes. Moreover, spleen and lymph nodes of mutant mice presented an altered architecture,
characterized by diffuse, irregular B cell areas and the absence of discrete perifollicular marginal
and mantle zones; the formation of secondary germinal centers in spleen was also impaired.
Proliferation of NF-
 
k
 
B2–deficient B cells was moderately reduced in response to lipopolysac-
charide, anti-IgD-dextran, and CD40, but maturation and immunoglobulin switching were
normal. However, 
 
nfkb
 
2 (
 
2
 
/
 
2
 
) animals presented a deficient immunological response to
T cell–dependent and –independent antigens. These findings indicate an important role of NF-
 
k
 
B2 in the maintenance of the peripheral B cell population, humoral responses, and normal
spleen architecture.
 
T
 
he 
 
nfkb
 
2 gene was originally cloned as a mitogen-
inducible cDNA encoding a protein with strong ho-
mology to NF-
 
k
 
B1 (p105/p50), a member of the Rel/NF-
 
k
 
B family of transcription factors (1–3). Neri et al. isolated
 
nfkb
 
2 as the protooncogene involved certain human B cell
lymphomas (4). More recently, several groups have docu-
mented that truncations in the COOH-terminal region of
this gene are associated with the development of cutaneous
T cell lymphomas, chronic lymphocytic leukemias, and mul-
tiple myelomas (5–8).
The Rel/NF-
 
k
 
B family of transcription factors plays a
major role as an early mediator of immune and inflammatory
responses (for reviews see references 9–14). This group of
proteins contains a highly conserved region named the Rel
homology domain that is responsible for both DNA bind-
ing and protein dimerization. In mammalian cells, this pro-
tein family can be divided into two classes: one class in-
cludes the NF-
 
k
 
B1 (p105/p50) and NF-
 
k
 
B2 (p100/p52)
proteins that are synthesized as precursor molecules (p105
and p100, respectively) that remain in the cytoplasm. Upon
proteolytic processing they generate the DNA binding sub-
units p50 and p52, respectively (1, 15–17). The second class
of proteins comprises RelA (p65), c-Rel, and RelB. These
proteins do not undergo proteolytic processing, and they har-
bor transcriptional activation domains. The different biolog-
ical functions of p50, RelA, RelB, and c-Rel have recently
been addressed by the generation of null mice (18–22).
In unstimulated cells, the Rel/NF-
 
k
 
B dimers associate
with members of the family of inhibitor proteins called I
 
k
 
Bs
and remain as an inactive pool in the cytoplasm. Upon stim-
ulation by different agents, I
 
k
 
B molecules are rapidly phos-
phorylated and degraded, allowing the NF-
 
k
 
B dimers to
translocate to the nucleus and regulate transcription through
binding to 
 
k
 
B sites (9, 12, 23–26). The in vivo function of
two members of the I
 
k
 
B family, I
 
k
 
B
 
a
 
 and Bcl-3, have been
recently analyzed in knockout mice (27–30).
The biological role of NF-
 
k
 
B2 (p100/p52) remains un-
clear despite the evidence that abnormal NF-
 
k
 
B2 expres-
sion correlates with cell transformation (31). Terminally dif-
ferentiated plasmacytoma and long term LPS-treated pre-B
and B cell lines express p52-containing complexes, imply-
ing that p52–c-Rel and p52/–RelB dimers play a role in
the final stages of B cell differentiation (32–33). Bcl-3, an
oncoprotein overexpressed in human chronic lymphocytic
leukemias, associates with p50 and p52 homodimers (34–
37). Transfection experiments show that these interactions
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lead to transactivation of 
 
k
 
B-dependent reporter constructs
(8, 35–36).
To further investigate the function of NF-
 
k
 
B2, we have
generated mice carrying a germline mutation of the 
 
nfkb
 
2
gene. NF-
 
k
 
B2-null mice have a marked reduction of the B
cell compartment in spleen, bone marrow, and lymph nodes
and are defective in the formation of secondary germinal
centers. B cells from mutant mice have mild proliferative
defects in response to LPS, mIg, and CD40, but have nor-
mal maturation and immunoglobulin switching. However,
 
nfkb
 
2 (
 
2
 
/
 
2
 
) mice have impaired humoral responses to T
cell–independent and T cell–dependent antigens when com-
pared to controls. These findings indicate an important role
for NF-
 
k
 
B2 in the maintenance of the peripheral B cell
population, germinal center formation, and B cell immune
function.
 
Materials and Methods
 
Targeting Vector.
 
To generate the pNF-
 
k
 
B2 targeting vector,
we isolated genomic fragments corresponding to the murine
 
nfkb
 
2 locus from a D3 embryonic stein (ES)
 
1
 
 cell genomic DNA
library in 
 
l
 
 Dash II (Stratagene, La Jolla, CA). The probe used for
the screening contained nucleotides 
 
1
 
1 to 
 
1
 
250 of the murine
 
nfkb
 
2 cDNA. 4 overlapping phages containing the promoter re-
gion and the first 20 exons of the 
 
nfkb
 
2 gene were obtained. As a
targeting strategy we introduced a mouse phosphoglycerate kinase–
promoter 
 
neo
 
 resistance cassette (38) into an EcoRI site present in
exon 4 of the 
 
nfkb
 
2 gene. For that purpose, a 10.5-kb EcoRI frag-
ment containing the 5
 
9
 
 region, exons 1–3 and part of exon 4 was
subcloned in the XhoI–NotI sites of the pPNT vector (39). Sub-
sequently, a 3.9-kb EcoRI fragment containing part of exon 4 to
exon 15 was introduced in the EcoRI site of the pPNT.
 
ES Cell Culture and Generation of Mutant Mice.
 
CJ7 ES cells
were cultured as previously described (40). The electroporation
was performed using 25 
 
m
 
g of NotI-linearized pNF-
 
k
 
B2 per 10
 
7
 
ES cells with a gene pulser (Bio-Rad Laboratories, Hercules, CA).
Cells were grown under double selection with G418 and fialuri-
dine. Colonies were picked 10 d after selection and expanded for
freezing and DNA extraction. Homologous recombinants (2 out
of 250 
 
neo
 
-resistant clones) were confirmed by Southern blot anal-
ysis with a 3
 
9
 
 external probe. Targeted ES cells were identified by
the appearance of a 5.3-kb recombinant band in addition to the
8.0-kb wild-type band in SpeI-digested DNA (Fig. 1 
 
A
 
 and 
 
B
 
).
 
nfkb
 
2 (
 
1
 
/
 
2
 
) ES cells were injected into C57BL/6 blastocysts
which were transferred into pseudopregnant ICR females. Re-
sulting chimeric mice were mated with C57BL/6 mice and het-
erozygous offspring were interbred to obtain 
 
nfkb
 
2-null animals.
The studies presented here were performed with line 3C and
subsequently confirmed using mice from line 5A. These studies
were performed according to guidelines established by the Bris-
tol-Myers Squibb Animal Care and Use Control Committee.
 
Histopathological Analysis and Immunohistochemistry.
 
Histopathologi-
cal analysis was performed on a minimum of five animals per age
group and genotype. Animals were killed and organs were fixed
by immersion in 10% neutral buffered formalin. Tissues were
processed by standard methods, embedded in paraffin blocks, sec-
 
tioned at 4–6 
 
m
 
m, stained with hematoxylin and eosin, and finally
examined by light microscopy. For immunohistochemical analysis,
frozen tissue sections were stained with anti-IgD (Southern Biotech-
nology Associates, Birmingham, AL; 1:200 dilution), MOMA-1
(Serotec Ltd., Oxford, UK; 1:100 dilution), peanut agglutinin
(PNA)-biotin (Vector Labs., Burlingame, CA; 80 
 
m
 
g/ml) and
FDC-M1 (1:100).
 
Cell Labeling and Immunoprecipitation.
 
Single-cell suspensions
from thymus were prepared as previously described (41) and cul-
tured in RPMI 1640 with 10% heat-inactivated fetal calf serum. 2 
 
3
 
10
 
7
 
 cells were labeled for 3 h with 500 
 
m
 
Ci/ml of [
 
35
 
S]methio-
nine in methionine-free medium with or without the addition of
PMA (10 ng/ml) and PHA (1 
 
m
 
g/ml). Cells were washed with
PBS and lysed in 1 ml of radioimmunoprecipitation assay buffer
without SDS. Extracts were precleared with preimmune serum (3
 
m
 
l), immunoprecipitated for 4 h with specific antiserum (3 
 
m
 
l),
and then incubated with Protein A–Sepharose CL-4B (Pharmacia
Biotech, Piscataway, NJ) for 3 h on a roller at 4
 
8
 
C. The immuno-
complexes were washed twice with buffer A (0.2 NP-40, 10 mM
Tris-HCl, pH 7.5, 150 mM NaCl, and 1 mM EDTA); once with
buffer B (0.2 NP-40, 10 mM Tris-HCl, pH 7.5, 500 mM NaCl,
and 2 mM EDTA); and once with buffer C (10 mM Tris-HCl,
pH 7.5). Samples were boiled in 30 
 
m
 
l of Laemmli buffer, and
separated on a 12.5% polyacrylamide gel (SDS-PAGE) at 12 mil-
liAmperes for 16 h. Gels were fixed and incubated with Entensify
(DuPont-NEN, Boston, MA). After drying, gels were exposed to
X-Omat AR film (Eastman Kodak Co., Rochester, NY) at 
 
2
 
70
 
8
 
C
overnight.
 
Preparation and Culture of B Cells.
 
The culture medium and re-
agents used for the B cell proliferation assays have been previously
described (42). Single cell suspensions from spleen were treated
with ammonium chloride buffer to lyse red blood cells. Cells were
stained with FITC-labeled rat IgG2a anti–mouse B220 mAb (clone
RA3-6B2; PharMingen, San Diego, CA) plus PE-labeled hamster
anti–mouse CD3e mAb (clone 145-2C11; PharMingen). Small,
resting B cells (B220
 
1
 
CD3
 
2
 
, low forward and side scatter profile)
were obtained by electronic cell sorting on an EPICS Elite cy-
tometer (Coulter Corp, Hialeah, FL). Reanalysis of sorted cells
immediately after isolation showed B cell purity of 
 
.
 
99%. Cells
were cultured at 37
 
8
 
C in a humidified incubator containing 6%
CO
 
2
 
 at a cell density of 2 
 
3
 
 10
 
5
 
 cells/ml.
 
Electrophoretic Mobility Shift Assays.
 
Whole cell extracts were
prepared as previously described (43). Protein concentrations
were determined with the Bio-Rad protein assay kit according to
the manufacturer’s instructions and were further analyzed by West-
ern blot analysis. Electrophoretic mobility shift assays (EMSAs)
were performed using 3 
 
m
 
g of protein extract and 5 
 
3
 
 10
 
4
 
 cpm of
 
32
 
P-labeled probe (
 
k
 
B palindromic; reference 37).
 
Measurement of DNA Synthesis by [
 
3
 
H]thymidine Incorporation.
 
Purified B cells (10
 
5
 
) were cultured for 72 h in a final volume of
0.2 ml in complete RPMI in flat-bottomed 96-well plates. [
 
3
 
H]thy-
midine was added to the cultures for an additional 18 h. Cultured
cells were then harvested onto glass fiber filter paper with a Wal-
lac 1295-001 cell harvester (LKB, Uppsala, Sweden). Specific in-
corporation of [
 
3
 
H]thymidine was analyzed by scintillation spec-
troscopy, and results are expressed as the arithmetic mean 
 
6
 
 SEM
of triplicate cultures.
 
Flow Cytometric Analysis.
 
Cells were resuspended in PBS con-
taining 1% bovine serum albumin before staining with the fol-
lowing conjugated antibodies: CD3, CD4, CD8, CD25, 
 
a
 
/
 
b
 
TCR, Thy 1.2, CD44, CD45R (B220), IgD, IgM, HSA, Ter-119,
Mac-1, Gr-1, F4/80, 7/4, and ICAM (intracellular adhesion mole-
cule)–1. Antibodies were obtained from GIBCO-BRL (Gaithers-
1Abbreviations used in this paper: EMSA, electrophoretic mobility shift as-
says; ES, embryonic stem; FDC, follicular dendritic cell; GC, germinal
center; PNA, peanut agglutinin; SRBC, sheep red blood cell.187 Caamaño et al.
burg, MD) and PharMingen. Flow cytometry was performed on
a FACScalibur flow cytometer (Becton-Dickinson Co., Moun-
tain View, CA) and 104 events were collected in each case.
Quantitation of Secreted Ig Isotype Concentrations in Culture Super-
natants. Purified B cells were stimulated with LPS (20 mg/ml),
IL-4 (4.2 ng/ml) 1 IL-5 (150 U/ml), sCD40L (10 mg/ml), anti–
IgD-dextran (3 ng/ml), TGF-b (3 ng/ml); and IFN-g (10 U/ml).
Ig isotype concentrations were measured by an ELISA assay as
previously described (44).
Immunization and ELISA Assays. To induce a T cell–depen-
dent response and analyze the formation of germinal centers in
the spleen, five mice of each genotype were immunized by intra-
peritoneal injection of either sheep red blood cells (SRBCs) or (4-
hydroxy-3-nitrophenyl) acetyl (NP-KLH). Each mouse was in-
jected with 250 ml of phosphate-buffered saline containing 10%
SRBCs (2.5 3 108 cells) or with 100 mg of alum-precipitated NP-
KLH. Animals were killed 10 d after immunization and spleens
were frozen in O.C.T. (Tissue-Tek, Miles Inc., Elkhart, IN) for
immunohistochemistry. Additional mice were also boosted with a
second injection of the same antigens 10 d after the first immuni-
zation, and the same assays were performed. The nfkb2-null mice
that were used to evaluate the basal immunoglobulin levels and
the antigen-specific immunoglobulin production have been pre-
viously backcrossed for eight generations to the C57 Bl/6 strain.
Basal levels of immunoglobulins were measured in sera col-
lected from control and nfkb2 null mice before immunizations.
For T cell–dependent responses, mice were immunized by intra-
peritoneal injection of 100 mg of alum-precipitated NP-KLH. In
the case of the T cell–independent responses, mice were immu-
nized with 10 mg of NP coupled to LPS (20, 44). Serum samples
were collected before immunizations and at 7-d intervals during
3 wk. To determine the levels of NP-specific immunoglobulins,
we used ELISA plates coated with NP17-BSA for capture, and
goat anti–mouse isotype-specific antibodies conjugated to horse-
radish peroxidase (Southern Biotechnology Associates) as previ-
ously described (45). The level of each antigen-specific isotype
was determined by comparison with a standard curve. NP-speci-
fic Ig levels in unchallenged mice were below detection. One sym-
bol represents one mouse. Statistical analysis was performed using
the unpaired Student’s t test to calculate second two-tailed P values.
Results
Generation of the nfkb2-null Mice. The strategy to gener-
ate the nfkb2-null allele in ES cells involved the introduc-
tion of a PGK-neo cassette in exon 4 of the mouse nfkb2 lo-
cus in an EcoRI site in nucleotide 54 of the nfkb2 open
reading frame (Fig. 1 A). Heterozygous nfkb2 (1/2) ani-
mals, containing the 8.0-kb wild-type and 5.3-kb recombi-
nant SpeI fragments, were crossed to obtain homozygous
mice (2/2) (Fig. 1 B). No differences in size, behavior, or
life span were observed between nfkb2-null mice and wild-
type littermates. These animals were born at the expected
Mendelian ratios, which demonstrates that NF-kB2 is not
required for normal embryo development. The presence of
the NF-kB2 protein was analyzed in thymocytes of control
and mutant mice. While thymic cells from wild-type mice
expressed p100/p52 upon stimulation, neither p100 nor
p52 were present in cells from the mutant mice, demon-
strating that the targeted disruption of the nfkb2 locus re-
sulted in a complete loss of both proteins (Fig. 1 C). The
nfkb2 (2/2) mice had no gross developmental deficiencies
or health abnormalities while maintained in a pathogen free
facility. No significant difference in protein levels of other
Rel/NF-kB family members was detected in thymus and
spleen whole cell extracts from mutant mice compared to
Figure 1. Generation of nfkb2-null mice. (A) The targeting vector
pNF-kB2 is shown at the top. The thin line depicts plasmid sequences,
the thick line represents intron sequences, and the closed boxes show ex-
ons of the nfkb2 gene. The open boxes correspond to the PGK-neo and
PGK-tk cassettes. The long arm contains a fragment of the 59 region, ex-
ons 1 to 3, and 33 nucleotides of exon 4 (EcoRI site). The short arm con-
tains the rest of exon 4 to exon 15. A homologous recombination event
between the targeting vector and wild-type genomic DNA introduces the
PGK-neo cassette into exon 4, disrupting the open reading frame of the
gene. (B) Southern Blot analysis of genomic DNA isolated from mouse
tails. 10 mg of DNA from mice of different genotypes were digested with
SpeI, run in 0.7% agarose gels, blotted according to standard procedures,
and hybridized with the 39 external probe A. The 8.0- and 5.3-kb frag-
ments correspond to the wild-type and targeted alleles respectively. (C)
Thymocytes from control (1/1) and nfkb2-null (2/2) mice were la-
beled with [35S]methionine for 3 h in the absence (lanes 1 and 3) or pres-
ence (lanes 2 and 4) of PMA/PHA (see Materials and Methods). Cell ex-
tracts were immunoprecipitated with NF-kB2–specific antiserum and
analyzed by SDS-PAGE. (D) EMSA profiles of the kB binding complexes
in whole cell extracts of thymus (Th) and spleen (Sp) from control (1/1)
and nfkb2-null mice (2/2). Extracts were incubated with preimmune se-
rum (p.i.), or antisera against p50 (ap50), p52 (ap52), or both, before the
addition of the kB palindromic oligo.188 NF-kB2–deficient Mice
control littermates by Western blot analysis (data not shown).
EMSAs using whole cell extracts from thymus of control
and nfkb2 (2/2) mice showed no remarkable differences
in their DNA binding (Fig. 1 D). In contrast, whole cell
extracts from splenocytes have a decrease DNA binding ac-
tivity corresponding to p52-containing complexes com-
pared to control cells (Fig. 1 D).
Histopathological Analysis of the nfkb2-null Mice. Light mi-
croscopic evaluation of all major tissues from nfkb2 (2/2)
mice of varying ages (3, 9, 12, 24, and 36 wk) showed that
histopathological changes were largely restricted to lym-
phoid organs. The thymus of the null mice was normal in
size, and corticomedullary ratios were similar to those ob-
served in wild-type age-matched animals (data not shown).
The spleen of the naive mutant mice was grossly similar to
wild-type controls. However, microscopic evaluation of
the spleen of nfkb2 (2/2) mice showed a disruption of the
normal architecture characterized by diffuse, irregular fol-
licular (B cell) areas with the absence of a discrete, perifol-
licular marginal zone and germinal centers (compare Fig. 2,
A and C). These morphologic abnormalities were substan-
tiated after immunohistochemical detection of B cells. In
Figure 2. Histopathologic and immunohistochemical analysis of the spleen of naive control and nfkb2 (2/2) mice. (A and C) Spleen sections stained
with hematoxylin and eosin from 8-wk-old control and nfkb2 (2/2) mice, respectively. F, follicles. Perifollicular marginal zones are indicated by ar-
rows. (B and D) Immunohistochemistry of consecutive spleen sections from A and C, respectively, stained with the B cell–specific mAb B220. GC, ger-
minal center. Bar equals 100 mm.189 Caamaño et al.
contrast to wild-type spleen where numerous B220 positive
(B2201) cells were observed within discrete germinal cen-
ters, the spleen from nfkb2 (2/2) mice presented B2201
cells scattered among indiscrete germinal centers (Fig. 2, B
and D). No differences were observed in the number of cells
undergoing apoptosis in the red or white pulp of the spleen
of unstimulated control and nfkb2 (2/2) mice as deter-
mined by Apoptag (Oncor, Inc., Gaithersburg, MD) his-
tochemical staining (data not shown). However, the num-
ber of Apoptag-positive cells in the splenic white pulp of
SRBC-stimulated nfkb2 (2/2) mice was decreased by
z70% as compared to the white pulp of SRBC-stimulated
control mice. The number of cells undergoing apoptosis in
the splenic red pulp of SRBC-stimulated nfkb2 (2/2) and
SRBC-stimulated control mice were similar.
Morphologic changes similar to those observed in B cell
areas in the spleen also occurred in lymph nodes of mutant
mice (data not shown).
Reduction of the B Cell Population in the Spleen, Bone Mar-
row, and Lymph Nodes from Mutant Mice. To further char-
acterize the histopathological changes observed in the nfkb2
(2/2) mice, we performed an extensive survey of surface
marker expression on hemopoietic cells from mutant mice.
Immunofluorescence staining and flow cytometric analysis
of thymocytes with anti-CD3, -CD4, -CD8, -CD25, and
-Thy 1.2 showed no remarkable changes between control
and mutant mice (data not shown). No difference in the
total cell number was observed in the thymus of null mice
with respect to the controls. Consistent with the initial his-
topathologic and immunohistochemical observations, the
spleen of the naive nfkb2-null mice presented a marked de-
crease in the B cell population. A 50–80% reduction in the
total number of B cells was detected in the spleen of mu-
tant mice as early as 1 wk after birth (Fig. 3 A). A concom-
itant increase of the T cell compartment comprising both
CD4 and CD8 single positive cells was detected in the
spleen of mutant mice (Fig. 3 A). A similar decrease in the
number of B cells and increase in the T cell population
were observed in older mice (Fig. 3, B and C). We also ex-
amined the stages of B cell differentiation by surface B220,
CD43, HSA, IgM, IgD, and CD19 expression. Both im-
mature and mature B cells were present in the spleen of the
nfkb2 (2/2) mice, indicating that a general reduction of all
the B cell lineages rather than a maturation blockage oc-
curred in the absence of NF-kB2. Similar results were ob-
served in the lymph nodes from mutant mice.
The bone marrow of the 6-wk-old nfkb2 (2/2) mice
have a normal number of B cells (Fig. 4 A). The total num-
ber of bone marrow cells recovered from control and nfkb2
(2/2) mice showed no significant differences. However,
mutant mice had a decline of 50% in the absolute number
of B cells between 8 and 12 wk of age in the bone marrow
(Fig. 4 B).
NF-kB2-deficient B Cells have Modest Proliferative Defects in
Response to LPS, mIg, or CD40 Signaling. Normally, B cells
stimulated with LPS, anti-CD40, or anti–IgD-dextran pro-
liferate, and these responses can be further augmented by
IL-4 and/or IL-5 addition. The signal transduction pathways
mediating these effects are distinct for each molecule, and
hence could be differentially affected by the absence of
NF-kB2 (45). In this context, and in light of the distinctive
roles for p50, c-Rel, and RelB in murine B cell prolifera-
tion (20, 21, 42, 45), we determined whether any of these
mitogenic pathways were dependent upon the expression
of NF-kB2. Highly purified resting B cells from naive
nfkb2 (2/2) and control mice were obtained by electronic
cell sorting and stimulated for 72 h with various concentra-
tions of LPS, anti–IgD-dextran, or anti-CD40 mAb in the
presence of IL-4 and IL-5. Similar results were obtained in
Figure 3. Reduction of the B cell population in the spleen of the
nfkb2-deficient mice. (A) Scatter plots of splenocytes stained with B220
versus Thy 1.2; CD4 versus CD8; IgM versus B220; and IgD versus B220
antibodies. Single cell suspensions of splenocytes from 12-wk-old control
(1/1) and mutant (2/2) mice were analyzed by flow cytometry as de-
scribed in Materials and Methods. Representative diagrams from four in-
dependent experiments are shown with the percentage of positive cells in
relevant quadrants. (B) Diagram showing the decrease in the total B cell
population in spleen of the nfkb2 (2/2) mice respective to the control
littermates at different time points. (C) Total T cells in the spleen of the
nfkb2-null mice at different time points.190 NF-kB2–deficient Mice
three independent experiments, which demonstrated only
moderate reduction in the proliferative response of NF-
kB2–deficient cells compared to control B cells (Fig. 5, A–C).
At concentrations between 2 and 10 ng/ml of anti–IgD-
dextran, NF-kB2–deficient B cells showed a nearly two-
fold reduction in their proliferative response compared to
controls. These results prompted us to analyze whether the
NF-kB2–deficient B cells were more prone to undergo
apoptosis upon stimulation. Splenocytes from control and
nfkb2-deficient mice have a similar number of B cells un-
dergoing apoptosis upon stimulation with anti–IgD-dex-
tran, anti-CD-40 mAb, or TNF-a as detected by FacsÒ anal-
ysis using anti-B220 and anti–Annexin V (data not shown).
B cells from nfkb2-null Mice have Normal Maturation to Ig
Secretion and Switching to Downstream Ig Isotypes In Vitro.
NF-kB2 has been shown to be expressed late during B cell
maturation, suggesting that it may regulate B cell matura-
tion to Ig secretion (32, 33). Furthermore, multiple Rel/
NF-kB binding sites have been identified in the Ig heavy
chain locus, including promoters and enhancers involved in
regulating Ig isotype switching (46, 47). Indeed, B cells
lacking NF-kB1 (p105/p50) have distinctive and selective
defects in Ig isotype switching (45). Thus, we tested the
relative ability of B cells lacking NF-kB2 (p100/p52) to
undergo B cell maturation to IgM secretion and switch to
the expression of downstream Ig isotypes in response to
various combinations of B cell activators and cytokines.
IL-4, IFN-g, and TGF-b induce class switching to IgG1
and IgE, IgG3 and IgG2a, and IgG2b and IgA, respectively,
in appropriately activated B cells (48). Combinations of
stimuli optimal for induction of class switching to different
sets of isotypes were used to assess switch recombination in
NF-kB2–deficient B cells. In two similar sets of experi-
ments, maturation to IgM secretion was essentially compa-
rable between B cells lacking NF-kB2 and similarly acti-
vated control B cells, in response to a variety of distinct
stimuli (Fig. 6). Likewise, induction of all six non-IgM,
non-IgD isotypes in NF-kB2–deficient B cells was compa-
rable to that observed for control B cells. The production
of IgM in NF-kB2-deficient B cells was two times higher
than in controls. Thus, in contrast to NF-kB1, NF-kB2 is
not essential for Ig isotype switching.
Impaired Antigen-specific Immunoglobulin Production in
nfkb2-null Mice. Mice rendered deficient for c-Rel, RelB,
NF-kB1 (p105/p50), or Bcl-3 have defective basal immu-
noglobulin levels and antibody production upon antigenic
challenge (20, 21, 29, 30, 49). To evaluate the humoral im-
munity of the nfkb2-null mice, we measured the basal pro-
duction of immunoglobulins in naive mutant and control
littermates and the statistical analysis was performed using
the Student’s t test (Fig. 7 A). While IgG1 and IgG2b
showed similar levels in control and nfkb2 (2/2) mice,
IgM (4.5-fold; P ,0.0005) and IgG2a (2-fold; P ,0.008)
were increased in null mice. In contrast, a threefold reduc-
tion in the levels of IgG3 (P ,0.01) and twofold lower lev-
els of IgA (P ,0.000004) were detected in the nfkb2-null
mice compared to wild-type littermates.
We next examined the humoral responses of control and
mutant mice to specific antigenic challenges. To assess the
T cell–dependent immune responses, mice were immu-
nized with keyhole limpet hemocyanin coupled to (NP-
KLH) and bled 7, 14, and 21 d after immunization. The
production of NP-specific isotype IgG1 by nfkb2 (2/2)
mice was reduced fourfold at day 7 (P ,0.008), and decrease
to 10-fold (P ,0.00001) at 21 d after treatment (Fig. 7 B).
The evaluation of the T cell–independent response was
performed using NP-LPS to immunize control and nfkb2-
null mice and the serum levels of NP-specific IgG3 were
measured at 7, 14, and 21 d after immunization (Fig. 7 C).
Under these conditions, the mutant mice had a 10-fold
lower production of specific antibody at day 7 (P ,0.01)
Figure 4. Changes in the B cell population in the bone marrow of the
nfkb2-deficient mice. Scatter plots of bone marrow cells stained with IgM
versus B220 from 6-wk-old (A) or 10-wk-old (B) control (1/1) and
mutant (2/2) mice were analyzed by flow cytometry as described in
Materials and Methods.
Figure 5. In vitro prolifera-
tion of B cells lacking NF-kB2.
Purified resting B cells from
nfkb2-null (open circles) and con-
trol mice (closed circles) were cul-
tured during 72 h at 105 cells/ml
in the presence of different con-
centrations of (A) LPS (0.09–20
mg/ml); (B) anti–IgD-dextran
(0.1–10 ng/ml); or (C) anti-
CD40 mAb (0.08–5 mg/ml) 1
IL-4 (3,000 U/ml) 1 IL-5 (150
U/ml). [3H]thymidine was
added for 12 h and cells were
then harvested for determination
of [3H]thymidine incorporation.
Values shown represent the means
of triplicate cultures 6 SEM.191 Caamaño et al.
and a 30-fold decrease 21 d after immunization (P ,0.02).
NP-specific Ig levels in unchallenged mice were below de-
tection. These results demonstrate that NF-kB2 is required
for normal levels of antigen-specific immunoglobulins, in
particular, in the absence of T cell help.
Impairment of Germinal Center Formation in nfkb2 (2/2)
Mice. The abnormal architecture of the spleen in the
nfkb2 (2/2) mice suggests that immune responses depen-
dent on cellular interactions in the follicles may not be fully
functional. To test this hypothesis we immunized mice
with SRBCs and evaluated the formation of germinal cen-
ters (GCs) 10 d after immunization. The spleen of wild-
type mice had numerous GCs characterized by B cell areas
that bound PNA surrounded by IgD1 cells (Fig. 8, A and
C). In contrast, the spleen of mutant mice had very few cells
stained by PNA and a diffuse perifollicular staining of cells
expressing surface IgD (Fig. 8, B and D). To further evalu-
ate the alterations of spleen follicular structure in the nfkb2
(2/2) mice, tissue sections from the immunized mice
were stained with MOMA-1, a specific antibody for me-
tallophilic macrophages (Fig. 8, E and F). While the spleen
of control mice had a ring-like zone of MOMA-1 1 cells
demarcating the marginal zone, the spleen of nfkb2 (2/2)
mice contained reduced numbers of loosely organized
MOMA-1–positive cells scattered throughout the white
pulp. MOMA-1 staining in the outer PALS showed no dif-
ferences between controls and nfkb2 (2/2) mice. The
presence of antigen presenting follicular dendritic cells
(FDCs), that promote B cell maturation, was analyzed by
Figure 6. NF-kB2 (2/2) B
cells have normal maturation to
Ig secretion and class switching
in vitro. Control (1/1) and
NF-kB2 (2/2) B cells were
stimulated as described in Mate-
rials and Methods. Concentra-
tions of secreted immunoglobu-
lins were measured in culture
supernatants by ELISA 6 d after
initiation of the cuture. The val-
ues represent the mean of tripli-
cate cultures.
Figure 7. Decreased immunoglobulin production in nfkb2-null mice.
(A) Resting immunoglobulin isotype levels in unimmunized mice. Serum
immunoglobulin levels in naive 7-wk-old littermates were determined by
isotype-specific ELISA. Closed circles correspond to control (1/1), open
circles to heterozygous (1/2), and open squares to mutant (2/2) mice.
(B) Immune response to the T cell–dependent antigen NP-KLH. Five lit-
termates of control (1/1, closed circles) and mutant (2/2, open squares)
mice were used for this assay. Serum samples were collected 7, 14, and 21 d
after immunization as indicated. (C) Immune response to the T cell–inde-
pendent antigen NP-LPS. Five control (1/1) and five mutant (2/2)
mice were used in this assay. Serum samples were collected at 7, 14, and
21 d after immunization. Horizontal lines indicate the mean values.192 NF-kB2–deficient Mice
immunostaining with the FDC-M1 monoclonal antibody
(50, 51). While clusters of FDCs could be clearly seen in
the GCs of the control mice, very few FDCs could be de-
tected in the mutant mice (Fig. 8, G and H).
Similar defects in the formation of GCs were observed
when mice received a second immunization boost of SRBC
10 d after the first one. In addition, nfkb2 (2/2) mice im-
munized with NP-KLH also displayed a lack of well de-
fined GC formation.
Discussion
Since the description of the NF-kB binding activity
more than 10 y ago (52), an extensive body of information
has been gathered describing the importance of this family
of proteins in the regulation of genes involved in cell growth,
stress, inflammation, and immune responses. An increasing
number of NF-kB target genes have been identified to date,
including cytokines, cytokine receptors, interferons, growth
factors, MHC proteins, and other genes. However, whether
or not particular members of the NF-kB family regulate
specific genes in different cell types, and the distinct biolog-
ical function of each protein, remain to be elucidated. In an
attempt to answer some of these questions, several labora-
tories have generated mice with mutated genes of the NF-kB
family. The data obtained indicate that the Rel/NF-kB
proteins play an important role in the hematopoietic sys-
tem. In brief, relA-deficient mouse embryos die at embry-
onic day 15 following massive apoptosis of hepatocytes in
the liver (18). Recent studies indicate that RelA has a role
in preventing TNF-a–induced apoptosis (53–55). Secre-
tion of IgG1 and IgA is reduced in RelA-deficient B cells
(56). Also, T and B cells lacking RelA show a marked re-
duction in their proliferative response. RelB-deficient mice
exhibit a T cell–dependent multiorgan inflammation, mye-
loid hyperplasia, and splenomegaly associated with ex-
tramedullary hemopoiesis (19, 22, 57). RelB-deficient B
cells have defective proliferative responses, although they
undergo normal cell maturation, Ig secretion and isotype
switching (42). On the other hand, c-Rel has been shown
to be required for lymphocyte activation and cytokine ex-
pression, as demonstrated by the B and T proliferative de-
fects and IL-2 production by T cell in c-Rel (2/2) mice
(20). The immune responses to T cell–dependent antigens
were defective in these mice.
Based on the studies mentioned above, the NF-kB pro-
teins can be divided into two groups according to the role
they play in the hematopoietic system. One of the groups
includes p50 and c-Rel, which regulate genes involved in
rapid immune responses. The other group comprises RelA
and RelB, which control the expression of genes impli-
cated in immune responses and also hemopoietic develop-
ment and housekeeping functions.
Immune Defects of nfkb2-null Mice. Here, we show that
NF-kB2 is required for B cell development and function.
First, nfkb2 (2/2) mice have a dramatic reduction in the
absolute number of B cells in peripheral lymphoid organs.
Second, NF-kB2 (2/2) B cells exhibited reduced in vitro
proliferation. Third, the number of B cells in the bone
marrow of the nfkb2 (2/2) mice undergoes a reduction of
50% between 8 and 12 wk of age.
In vitro, NF-kB2 (2/2) B cells display normal cell mat-
Figure 8. Impaired formation of GC in nfkb2 (2/2) mice. Control
(1/1) and mutant (2/2) mice were injected with SRBCs. Animals
were killed 10 d after immunization, and then spleens were collected and
processed for frozen tissue sections. A and B correspond to PNA, C and
D to anti-IgD, E and F to MOMA-1, and G and H to FDC-M1 staining
of spleen sections. A–D have the same magnification (bar in D equals 75
mm). E and F have the same magnification (bar in F equals 100 mm).
Magnification in G and H is identical (bar in H equals 50 mm).193 Caamaño et al.
uration to immunoglobulin secretion and class switching.
The number of splenic T cells is increased although stimu-
lation-induced proliferation is normal in the absence of
NF-kB2. In addition, the nfkb2 (2/2) mice have an ab-
normal splenic microarchitecture, with diffuse B cell areas,
lack of lymphoid follicles, and a discrete marginal zone, an
area where nfkb2 transcripts have been previously shown (58).
Challenges with T cell–dependent or –independent anti-
gens showed that the nfkb2 (2/2) mice are impaired in the
production of antigen-specific antibodies. Consistent with
these defective antibody responses, the spleen of nfkb2 (2/2)
mice lacks well-defined GC structures. The absence of cen-
trocytes and a decreased number of metallophilic macro-
phages and FDCs are some of the characteristics of the GCs
in the mutant mice. Such centers are the primary sites
where T–B cell communication takes place, together with
B cell expansion, somatic hypermutation, isotype switch-
ing, and affinity maturation (59–62).
Our results suggest that either the production or the
lifespan of B cells is defective in nfkb2 (2/2) mice. In ad-
dition, the migration of the B cells to the peripheral lym-
phoid organs may be deficient. Moreover, the low number
of splenic B cells in these mutant mice coupled with the
marked reduction of FDCs and the lack of GCs results in
impaired immune responses. Thus, NF-kB2 regulates the
expression of genes involved in B cell production, forma-
tion of GCs, and normal levels of antigen-specific antibod-
ies. Although the genes regulated by NF-kB2 are still un-
known, we are starting to understand the pathways in
which this protein is involved. Further studies will be nec-
essary to clarify whether nfkb2-null B cells are intrinsically
defective or exhibit abnormalities as a consequence of im-
paired T lymphocytes, dendritic cells, or the microenviron-
ment of the spleen.
Similar defects in the formation of GCs have been de-
scribed in mice deficient in different ligands and receptors
including CD40, CD40L, TNF-a, LT-a, TNF receptor I,
MHC class II, CD28, the putative chemokine receptor
BLR1, the complement receptor locus Cr II, and OBF-1,
the B cell–specific coactivator of Oct-1 and Oct-2 (63–72).
Interestingly, CD40, TNF-a, and LT-a signaling induce
NF-kB binding activity, suggesting that p52 may have a
role in the signal transduction pathways triggered by these
molecules (73–75).
Several phenotypic defects are common between bcl-3
(2/2) and nfkb2 (2/2) mice (29, 30). Mice rendered de-
ficient for Bcl-3 also have a decreased B cell population,
impaired formation of GCs, and severe defects in the pro-
duction of antigen specific antibodies. Such strong similari-
ties argue for a synergistic effect of these two proteins in
transcription (35).
Functional Redundancy between p105/p50 and p100/
p52. The phenotype of the nfkb2-deficient mice is quite
distinct from that of mice rendered deficient in other mem-
bers of the NF-kB family of transcription factors. Although
NF-kB2 (p100) is 52% homologous to NF-kB1 (p105; ref-
erences 1, 3, 4), their pattern of expression is different. While
nfkb1 is ubiquitously expressed in mouse tissues, nfkb2 ex-
pression is more restricted to lymphoid organs, and the
highest mRNA levels are found in thymic medulla, mar-
ginal zone, and outer region of the periarterial sheath of the
spleen (58). A comparison between the phenotypic changes
displayed by mice lacking NF-kB1 and NF-kB2 reveals
significant differences but also some similarities. The nfkb2-
null mice have an abnormal splenic architecture and im-
paired formation of secondary GCs. In contrast, the nfkb1-
null mice do not have any of these deficiencies (21, 30). B
cells from nfkb1-null mice have a very poor proliferative re-
sponse to LPS, but respond normally to anti–IgD-dextran
and anti-CD40. In the case of nfkb2-null mice, B cells ex-
hibit a moderate decrease in proliferation in the presence of
similar stimuli. These data indicate that NF-kB1/p50 has a
key role in the LPS stimulatory pathway, whereas NF-
kB2/p52 has a modest effect on proliferation independent
of the pathway. Another important difference in the roles
of NF-kB1/p50 and NF-kB2/p52 is that nfkb1-null B cells
have defects in their maturation and immunoglobulin se-
cretion, germ line CH transcription, and isotype switching
(21, 45), whereas nfkb2 (2/2) B cells do not exhibit any of
these deficiencies. However, the production of antigen-
specific antibodies is affected in mice mutant for either NF-
kB1 or NF-kB2. T cell–dependent responses are impaired
in nfkb1 mutant mice and reduced in nfkb2-null mice. T
cell–independent immune responses are severely impaired
in nfkb2-null mice.
These phenotypic differences between nfkb1 and nfkb2
mutant mice clearly indicate that p105/p50 and p100/p52
have distinct functions in the B cell lineage. However, we
still cannot rule out a functional redundancy for these pro-
teins. Further experiments generating double mutant mice
should help to clarify this matter.
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